Evidence map›Paper›PMID 32915805›Full record

ArticlePloS one2020

Gallbladder polyps: Correlation of size and clinicopathologic characteristics based on updated definitions.

Orhun C Taskin, Olca Basturk, Michelle D Reid, Nevra Dursun, Pelin Bagci, Burcu Saka, Serdar Balci, Bahar Memis, Enrique Bellolio, Juan Carlos Araya and 9 more

Erratum issuedAbstract read
In one paragraph

Article in PloS one, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 16 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Guideline
  2. Pooled it
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Polypoid invasive carcinoma of bile duct: report of four cases.Clinical journal of gastroenterology · 2022
    Article
  13. Article
  14. Article
  15. Review
  16. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

19 authors.

Orhun C TaskinDepartment of Pathology and Research Center for Translational Medicine (KUTTAM), Koç University, Istanbul, Turkey.ORCID 0000-0002-6668-3006
Olca BasturkMemorial Sloan Kettering Cancer Center, Department of Pathology, New York, NY, United States of America.
Michelle D ReidDepartment of Pathology, Emory University, Atlanta, GA, United States of America.
Nevra DursunDepartment of Pathology, Istanbul Research and Training Hospital, Istanbul, Turkey.
Pelin BagciDepartment of Pathology, Marmara University Pendik Research and Training Hospital, Istanbul, Turkey.
Burcu SakaDepartment of Pathology, Medipol University, Istanbul, Turkey.
Serdar BalciDepartment of Pathology, Emory University, Atlanta, GA, United States of America.ORCID 0000-0002-7852-3851
Bahar MemisDepartment of Pathology, Şişli Hamidiye Etfal Training and Research Hospital, Istanbul, Turkey.
Enrique BellolioAnatomic Pathology Department, Universidad de La Frontera, Temuco, Chile.
Juan Carlos ArayaDepartment of Pathology, Hospital Dr. Hernan Henriquez Aravena, Temuco, Chile.
Juan Carlos RoaDepartment of Pathology, Pontificia Universidad Catolica de Chile, Santiago, Chile.
Oscar TapiaDepartment of Pathology, Pontificia Universidad Catolica de Chile, Santiago, Chile.
Hector LosadaDepartment of Surgery and Traumatology, Universidad de La Frontera, Temuco, Chile.
Juan SarmientoDepartment of Surgery, Emory University, Atlanta, GA, United States of America.
Kee-Taek JangDepartment of Pathology, Emory University, Atlanta, GA, United States of America.ORCID 0000-0001-7987-4437
Jin-Young JangDepartment of Surgery, Seoul National University College of Medicine, Seoul, Korea.
Burcin PehlivanogluDepartment of Pathology, Adiyaman Training and Research Hospital, Adiyaman, Turkey.
Mert ErkanDepartment of Surgery and Research Center for Translational Medicine (KUTTAM), Koç University Hospital, Istanbul, Turkey.
Volkan AdsayDepartment of Pathology and Research Center for Translational Medicine (KUTTAM), Koç University, Istanbul, Turkey.ORCID 0000-0002-1308-3701

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Hongbiao Carl Lekaye · 1985 to 2026
$347.4M
NCI NIH HHS P30 CA008748
6 · The paper itself

Abstract

backgroundDifferent perspectives exist regarding the clinicopathologic characteristics, biology and management of gallbladder polyps. Size is often used as the surrogate evidence of polyp behavior and size of ≥1cm is widely used as cholecystectomy indication. Most studies on this issue are based on the pathologic correlation of polyps clinically selected for resection, whereas, the data regarding the nature of polypoid lesions from pathology perspective -regardless of the cholecystectomy indication- is highly limited.

methodsIn this study, 4231 gallbladders -606 of which had gallbladder carcinoma- were reviewed carefully pathologically by the authors for polyps (defined as ≥2 mm). Separately, the cases that were diagnosed as "gallbladder polyps" in the surgical pathology databases were retrieved.

results643 polyps identified accordingly were re-evaluated histopathologically. Mean age of all patients was 55 years (range: 20-94); mean polyp size was 9 mm. Among these 643 polyps, 223 (34.6%) were neoplastic: I. Non-neoplastic polyps (n = 420; 65.4%) were smaller (mean: 4.1 mm), occurred in younger patients (mean: 52 years). This group consisted of fibromyoglandular polyps (n = 196) per the updated classification, cholesterol polyps (n = 166), polypoid pyloric gland metaplasia (n = 41) and inflammatory polyps (n = 17). II. Neoplastic polyps were larger (mean: 21 mm), detected in older patients (mean: 61 years) and consisted of intra-cholecystic neoplasms (WHO's "adenomas" and "intracholecystic papillary neoplasms", ≥1 cm; n = 120), their "incipient" version (<1 cm) (n = 44), polypoid invasive carcinomas (n = 26) and non-neoplastic polyps with incidental dysplastic changes (n = 33). In terms of size cut-off correlations, overall, only 27% of polyps were ≥1 cm, 90% of which were neoplastic. All (except for one) ≥2 cm were neoplastic. However, 14% of polyps <1 cm were also neoplastic. Positive predictive value of ≥1 cm cut-off -which is widely used for cholecystectomy indication-, was 94.3% and negative predictive value was 85%.

conclusionsApproximately a third of polypoid lesions in the cholecystectomies (regardless of the indication) prove to be neoplastic. The vast majority of (90%) of polyps ≥1 cm and virtually all of those ≥2 cm are neoplastic confirming the current impression that polyps ≥1 cm ought to be removed. However, this study also illustrates that 30% of the neoplastic polyps are <1 cm and therefore small polyps should also be closely watched, especially in older patients.

Indexed as

AdultAgedAged, 80 and overArea Under CurveDatabases, FactualGallbladderGallbladder NeoplasmsHumansMiddle AgedPolypsROC CurveYoung Adult

Identifiers

PMID32915805
PMCPMC7485812

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.